on 29 Aug 2023
Last Applicant/ Owned by
Porton Down Salisbury, Wiltshire SP4 0BF
GB
Serial Number
79351011 filed on 20th Jul 2022
Registration Number
7147580 registered on 29th Aug 2023
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or facRead More
Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or factor XIIa mediated diseases or disorders
Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders
Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders
No 79351011
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 23rd Oct 2023 | NOTIFICATION PROCESSED BY IB |
| 29th Sep 2023 | FINAL DISPOSITION PROCESSED |
| 29th Sep 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 28th Sep 2023 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| 29th Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
| 13th Jun 2023 | PUBLISHED FOR OPPOSITION |
| 24th May 2023 | NOTICE OF PUBLICATION |
| 06th May 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 05th May 2023 | ASSIGNED TO EXAMINER |
| 04th Oct 2022 | APPLICATION FILING RECEIPT MAILED |
